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In order to identify early transcriptional targets of MyoD prior to skeletal muscle differentiation, we
have undertaken a transcriptomic analysis on gastrula stage Xenopus embryos in which MyoD has been
knocked-down. Our validated list of genes transcriptionally regulated by MyoD includes Esr1 and Esr2,
which are known targets of Notch signalling, and Tbx6, mesogenin, and FoxC1; these genes are all are
known to be essential for normal somitogenesis but are expressed surprisingly early in the mesoderm.
In addition we found that MyoD is required for the expression of myf5 in the early mesoderm, in
contrast to the reverse relationship of these two regulators in amniote somites. These data highlight a
role for MyoD in the early mesoderm in regulating a set of genes that are essential for both myogenesis
and somitogenesis.
& 2012 Elsevier Inc. All rights reserved.Introduction
In vertebrates, the myogenic regulatory genes myoD, myf5,
myogenin, and mrf4 code for bHLH transcription factors which are
expressed speciﬁcally in the myogenic cell lineage. These MRFs
(myogenic regulatory factors) act as developmental switches,
committing cells to skeletal myogenesis. MRF expression provides
the earliest marker of myogenic precursors (reviewed, (Pownall
et al., 2002) and are critical players in the establishment of this
lineage, acting as dominant regulators of myogenesis (reviewed,
Weintraub, 1993). While mouse knock-outs have shown that the
functions of these genes are somewhat overlapping, it is clear that
myoD, myf5 and mrf4 are essential for the early establishment of
the myogenic lineage since mice deﬁcient in these genes do not
form any skeletal muscle, and also lack all skeletal muscle
precursors (Rudnicki et al., 1993). Much work has been under-
taken investigating the regulation of MRF gene expression
(for instance, Carvajal et al., 2001) and the transcriptional
mechanisms by which the MRFs drive skeletal muscle differentia-
tion (Tapscott, 2005). However, very little is known about what
genes these important transcription factors regulate prior to
myogenic differentiation.
In Xenopus, XmyoD and Xmyf5 are expressed at high levels in
the myogenic lineage prior to differentiation (Hopwood et al.,
1989) and importantly, XmyoD protein is also present in gastrula
stage embryos many hours before differentiation of skeletal
muscle (Hopwood et al., 1992). A mesodermal cell from an earlyll rights reserved.
zabeth Pownall).gastrula embryo requires continued cell signals, such as FGF4, to
maintain a myogenic fate (Standley et al., 2001), however, a single
cell taken from a late gastrula embryo behaves as a determined
myoblast: when transplanted to a ventral region, it differentiates
as skeletal muscle (Kato and Gurdon, 1993). These cells in the
Xenopus gastrula therefore represent a population of XmyoD
positive, myogenic progenitors. In amniotes, a similar pool of
muscle progenitors is present in the medial edge of the dermo-
myotome (Denetclaw et al., 1997). In both cases, the myogenic
progenitor cells express one or more MRFs and are committed to
give rise to skeletal muscle, but do not yet express any differ-
entiation markers such as the contractile protein genes (de la
Brousse and Emerson, 1990; Emerson, 1990). When compared to
amniotes, myogenic progenitor cells in the amphibian gastrula
are more easily accessible and we have taken advantage of this to
look for genes regulated by MyoD prior to myogenic differentia-
tion in vivo.
A microarray expression analysis has been used to identify
genes that require MyoD for their expression in the mesoderm
during gastrula stages (NF 11.5). We have found that MyoD
protein is required to activate transcription from a set of genes
that include Esr1, Esr2, mesogenin (mespo), Tbx6 and FoxC1; all
known to be important for normal somitogenesis (Hitachi et al.,
2008; Oginuma et al., 2008; Tazumi et al., 2008; Topczewska
et al., 2001). Esr1 and Esr2 are Hairy/enhancer of split (HES) related
genes that are downstream effectors of Notch signalling, which is
a central part of the segmentation clock that regulates the regular
formation of somites from the presegmental plate mesoderm
(Rida et al., 2004). All skeletal muscles in the vertebrate body are
derived from the somites, and in amniotes the expression of
the MRFs is closely associated with the segmentation of somites
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regulation of somitogenesis and that of myogenesis have largely
been investigated independently. Our data identify a set of genes
important for somitogenesis that are transcriptionally activated in
the early mesoderm as direct targets of the skeletal muscle
speciﬁc transcription factor MyoD. This analysis may reveal an
unexpected ancestral link between the molecular mechanisms
that regulate skeletal muscle lineage determination and genes
important for somitogenesis.Materials and methods
Microinjections
Antisense morpholino oligos (AMOs) were designed to target
both MyoD alleles in Xenopus laevis: XMyoDa (Morpholino A:
50 ACAGCTCCATAGCAACAGCGCAAAG 30) and XMyoDb (Morpho-
lino B: 50 GTCCCAGGCCAAATACCCGCAGTTTG 30). An effective
dose of 10 ng Morpholino A and 30 ng Morpholino B was
determined empirically and used throughout this study. For the
controls, an equivalent 40 ng dose of GeneTools standard control
oligo (CMO: 50 CCTCTTACCTCAGTTACAATTTATA 30) was injected.
Microarray sample preparation and analysis
Total RNA was extracted from ﬁve whole embryos at NF stage
11.5 (Nieuwkoop and Faber, 1967) using TRI-Reagent (Sigma) as
per the manufacturer’s instructions. Embryos were either experi-
mental MyoD AMO or control CMO injected embryos; three
separate samples were prepared from embryos from three differ-
ent matings. In another experiment, total RNA was extracted from
50 animal caps, either from control embryos or embryos over-
expressing MyoD. RNA was further processed using the QIAgen
RNeasys kit (QIAgen) followed by lithium chloride precipitation.
About 5 mg of animal cap and 2 mg of whole embryo total RNA
was ampliﬁed and biotin labelled using the MessageAmp
TM
II
Biotin enhanced Single Round aRNA Ampliﬁcation Kit (Ambion)
as per the manufacturer’s instructions. Biotinylated aRNA was
then hybridised to the array and the array scanned by the
Genomics Laboratory at the University of York Technology Facility.
Data were analysed using the BRB-ArrayTools plug in for Micro-
softs Excel software. CEL ﬁles were imported and RMA normal-
isation performed. All genes which were called as absent by the
software in more than 75% of samples were discarded. Class
comparison analysis was carried out on the remaining genes in
the case of triplicate data from knock-down embryos. For animal
cap samples a 2-fold cut-off value was used to produce gene lists
of up-regulated genes.
Whole mount in situ hybridisation
Antisense digoxygenin (DIG) labelled RNA probes were
synthesized using the plasmids, restriction enzymes and poly-
merases described in the Supplementary data. In situ hybridisa-
tion was carried out as modiﬁed from Harland (1991). Brieﬂy,
de-membraned embryos were ﬁxed in MEMFA (0.1 M MOPS pH
7.4, 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde) and treated
with 10 mg/ml Proteinase K before hybridising in 50% Formamide,
5 SSC pH 7, 1 mg/ml total yeast RNA, 100 mg/ml Heparin,
1Denhardts, 0.1% Tween 20, 0.1% CHAPS, and 10 mM EDTA
overnight at 60 1C. After extensive washes, embryos were incu-
bated in a 1/2000 dilution of afﬁnity puriﬁed anti-digoxygenin
antibody coupled to Alkaline Phosphatase (Roche) at 4 1C over-
night. Expression was visualised using BM purple (Roche).Chromatin immunoprecipitation
Multiple alignments were carried out using the tool MultiPIP-
maker. The gapped BLASTZ alignments obtained were then scanned
for the E-box consensus sequence ‘‘CANNTG’’. Once a region
containing a conserved E-box was found, the surrounding 200 base
pairs were identiﬁed in each genome and Clustal-W alignment was
performed on these shorter sequences to conﬁrm the presence and
the conservation of an E-box (Supplementary data).
Chromatin immunoprecipitation was performed as in Blythe
et al. (2009). Xenopus tropicalis embryos were injected bilaterally
with 500 pg of XtMyoDmRNA and crosslinking was carried out by
ﬁxing (1% formaldehyde/PBS) for 1 h. Embryos were homogenised
on ice in the presence of proteinase inhibitors and sonicated
before incubation with pre-blocked protein G beads (Sigma)
followed by the anti-MyoD antibody D7F2 (DSHB) or goat anti-
mouse unconjugated IgG (Sigma) overnight at 4 1C. Samples were
then washed, eluted from beads, and reverse-crosslinked at 65 1C.
Some supernatant was used in a Western blot to conﬁrm MyoD
pull down. After crosslink reversal and proteinase K treatment,
nucleotides in the samples were puriﬁed by phenol:chloroform
extraction and treated with100 m/ml RNAse A and 4000 m/ml
RNAse T1 (Ambion). Samples were then puriﬁed using the
QIAquicks PCR (QIAgen) puriﬁcation kit. The DNA samples were
then subject to PCR targeted to genomic regions using the primers
listed in the Supplementary data. An initial 25 cycles of PCR was
followed by a second round of 25 cycles using one-ﬁfth of the
initial reaction. The resulting products were run on a 3% agarose
gel.
Western blots
For analyses of MyoD protein, 10 whole embryos at the stages
indicated were homogenised in Phosphosafe homogenising buffer
(Merk) and processed as described in Hopwood et al. (1992).
Samples were run on an 11% SDS-PAGE gel and transferred onto a
PVDF membrane. A 1:4 dilution of D7F2 tissue culture super-
natant (DSHB) was used for MyoD and a 1:100,000 dilution of
anti-GAPDH-71.1 antibody (Sigma) for GAPDH. A 1:3000 dilution
of anti-mouse POD secondary antibody (Amersham) was used for
both primaries. Proteins were visualised using an ECL detection
kit (Roche).
RNAse protection
RNAse protections were carried out as described in Isaacs et al.
(1994) using probes prepared from plasmids using the restriction
enzymes and polymerases described in the Supplementary data.
Probes were hybridized overnight at 45 1C and RNAse digestion
was carried out for 45 min at 37 1C.
qPCR
cDNA was synthesised from total RNA isolated from three
experimental replicates using AMV reverse transcriptase cDNA
synthesis kit (Roche) as per the manufacturer’s instructions with
the supplied oligo d(T) primers. Gene speciﬁc primers were
designed using ABI Primer Expresss II software and are listed in
Supplementary data. These primers were then used in a Power
SYBRs Green (ABI) reaction using an ABI Prism 7000 sequence
detection machine and software. The Ct values from three
technical replicates and primer efﬁciency were then exported
into REST
TM
2008 software for statistical analysis, using the Pfafﬂ
method of quantiﬁcation and a pair-wise ﬁxed reallocation
randomisation test. ODC was used as the transcript for normal-
ising the data throughout.
Fig. 1. Temporal expression proﬁle of MyoD and a-cardiac actin. (A) A western
blot using D7F2 shows the presence of MyoD protein at the stages indicated.
MyoD protein does not become detectable until stage 10.5. A background band is
present at all time points and runs at a size just below that of MyoD. The band
corresponding to MyoD is indicated with an arrow head. (B) RNAse protection
assay for a-cardiac actin expression, an early marker of skeletal muscle differ-
entiation. mRNA coding for a-cardiac actin is not detectable until stage 12.5.
ODC expression serves as a loading control. (C) A microarray time course analysis
was undertaken to determine the temporal proﬁle of MyoD and a-cardiac actin
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X. laevis embryos were ﬁxed for whole mount immunohisto-
chemistry for 1 h in MEMFA and stored in methanol at 20 1C.
Embryos were rehydrated through a series of methanol/ PBSþ1%
Triton X-100 (Sigma) washes, blocked in PBSTþ0.1% BSA and then
incubated at 4 1C overnight in either a 1:2 dilution of 12/101
mouse monoclonal antibody tissue culture supernatant (DSHB),
or 1:100 anti laminin rabbit polyclonal antibody (Sigma, L9393).
After extensive washes, embryos were placed in either a 1:500
dilution of goat anti mouse F(ab) fragments coupled to horse
radish peroxidase (Abcam, AB5880) or goat anti rabbit Alexa
Flours 488 (Invitrogen, A11034) and incubated overnight at
4 1C. Antibody staining was visualised either by using 0.5 mg/ml
DAB in PBST with 1:6000 hydrogen peroxide, or on a Zeiss
LSM710 microscope using the appropriate ﬁlters. Embryos pro-
cessed for confocal microscopy were cleared and mounted for
imaging in 1:2 benzyl alcohol: benzyl benzoate (BA:BB).
Cryosections
Cryosectioned embryos were prepared as in Roth et al. (2010)
with the following modiﬁcations: prior to sectioning, embryos
ﬁxed in MEMFA were transferred to 15% ﬁsh gelatine/15% sucrose
for 16 h followed by a second 16 h incubation in 25% ﬁsh gelatine/
15% sucrose. Primary antibodies used were as above, but 12/101
was used at 1:10. Secondary antibodies were a 1:250 dilution of
goat anti-rabbit Alexa Flour 488s and goat anti mouse Alexa
Flours 555 (Invitrogen, A21424).
Histology
Histological sectioning and counterstaining were carried out as
in Winterbottom et al. (2011). Brieﬂy, embryos were ﬁxed in
4% paraformaldehyde (Sigma), and stained with borax carmine
(10% borax carmine, 35% ethanol) before embedding in Paraplast
(Sigma) and cutting 10 mm sections. The sections were counter-
stained with picro blue black (97.5% saturated picric acid, 2.5% of
a 1% aqueous solution of naphthalene blue black) and mounted in
Histomount (National Diagnostics).gene expression. MyoD mRNA levels (blue) start to rise just before its protein
becomes detectable, whereas a-cardiac actin mRNA levels (red) do not begin to
rise until stage 12.5. The time window corresponding to when myogenic
precursors that express MyoD protein are present, but not markers of differentia-
tion is shown by the hatched grey area. (D) Three fertilisations from different
matings were used to generate three biological samples for microarray analysis.
Effective knock-down of MyoD in each experimental set was conﬁrmed by
Western blotting for D7F2.Results
Zygotic activation of MyoD expression occurs during early
gastrulation, from approximately NF stage 10 (Hopwood et al.,
1989) and MyoD protein is detectable very soon after this, from
NF stage 10.5 (Fig. 1A) (Hopwood et al., 1992; Harvey, 1992). The
expression of contractile protein genes and other genes that
characterise myogenic differentiation is not detected until 3–4 h
later at late gastrula/early neurula stages. a-cardiac actin is one of
the ﬁrst skeletal muscle genes expressed and it is not detected
until late gastrula NF stage 12.5 (Fig. 1B). In order to determine
the transcriptional targets of MyoD prior to myogenic differentia-
tion, we have analysed gene expression in embryos depleted of
MyoD protein at this time-point in development: after MyoD
protein is present and prior to the expression of differentiation
genes (NF stage 11.5). As part of our analysis we have also used a
data set that allows temporal expression proﬁling of individual
genes of interest (EMBL ArrayExpress accession number E-MEXP-
2059; described in Branney et al., 2009). These data are useful for
this study because the early transcriptional targets of MyoD will
increase in expression soon after MyoD protein is detected,
and prior to the increase in expression seen for a-cardiac actin
(red line, Fig. 1C).Large-scale analysis of gene expression in embryos lacking MyoD
As X. laevis is an allotetraploid organism, both pseudoalleles,
XMyoDa and XMyoDb, must be targeted to attain complete knock-
down. Fertilisations were prepared from three different female–
male pairings to provide three biological samples and translation
blocking antisense morpholino oligomers (AMOs) targeting both
alleles were injected into both blastomeres at the two-cell stage.
Effective knock-down of MyoD protein in each sample was deter-
mined by Western blotting (Fig. 1D) using a well-characterised
monoclonal antibody, D7F2, which recognises both XMyoDa and
XMyoDb (Hopwood et al., 1992). Microarray analysis was carried
out on NF stage 11.5 embryos using ﬁrst-generation Affymetrix
GeneChip X. laevis arrays.
Data obtained were analysed using BRB Arraytools and a class
comparison between the control and injected sets of embryos was
performed (Tusher et al., 2001). After the elimination of multiple
probe sets representing the same gene, and using a signiﬁcance
Fig. 2. Microarray analysis of MyoD knock-down embryos at NF stage 11.5. (A) A scatterplot of log2 gene expression values in control morpholino injected embryos at NF
stage 11.5 versus embryos injected with MyoD morpholino oligos A and B. Probe sets showing greater than 2-fold changes of expression in control versus experimental
groups are indicated by red and green points. Gene ontology (GO) terms associated with down- and up-regulated genes were used to classify MyoD target genes based on
the GO category molecular function (MF). (B) A table of GO terms associated with genes down-regulated in MyoD knock-down embryos. (C) A table of GO terms associated
with genes up-regulated in MyoD knock-down embryos.
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to be down-regulated and 59 genes up-regulated when MyoD is
knocked-down (ArrayExpress accession number E-MEXP 3272).
Fig. 2 shows a scatterplot of log2 gene expression values in control
morpholino injected embryos at NF stage 11.5 versus embryos
injected with MyoD morpholino oligos A and B. Probe sets
showing greater than 2-fold changes of expression in control
versus experimental groups are indicated by red and green points.
An analysis of gene ontology (GO) terms associated with
down-regulated and up-regulated genes was undertaken so that
where possible we have classiﬁed MyoD target genes based on
the GO category molecular function (MF). An initial analysis was
performed using GO:Slim categories and a 1.75-fold enrichment
cut-off to provide an overview of gene functions present. In order
to provide a robust view of which GO terms were over-
represented or under-represented in the gene groups identiﬁed,
a statistical analysis of the GO terms was undertaken using the
online tool DAVID (http://david.abcc.ncifcrf.gov/home.jsp), which
applies a modiﬁed version of Fisher’s exact test. A signiﬁcance
level of pr0.05 was applied to the MF GO terms associated with
the different groups of genes. This analysis shows that all
signiﬁcantly over-represented GO terms associated with genes
positively regulated by MyoD are associated with DNA binding
and transcriptional activity (Fig. 2B). In contrast, all signiﬁcantly
over-represented terms associated with genes negatively regu-
lated by MyoD are associated with cell signal transduction and
nucleotide metabolism and other metabolic processes (Fig. 2C).
For our purposes, a list of genes down-regulated in MyoD
knock-down embryos was compiled by comparing gene expres-
sion in MyoD AMO injected embryos to CMO injected embryos.
The criteria of a 2-fold decrease in expression and a signiﬁcance
level of pr0.05 were used as an initial selection tool; however,
the fold increase of expression in response to MyoD overexpres-
sion in animal caps was also considered when selecting the
putative targets to investigate further. Table 1 shows a curated
shortlist of some of the most highly down-regulated targets in
MyoD knock-down embryos and also the fold increase of each
gene when MyoD is overexpressed in animal caps. The putative
MyoD targets highlighted on this shortlist were analysed further
in this study.The change in gene expression shown on Table 1 is the output
from Affymetrix array analysis; we have validated these data
using qPCR. Data from three separate experiments (Supplemen-
tary Fig. S1A) conﬁrm that MyoD is essential for the normal
expression of the putative target genes, Esr1, Esr2, FoxC1, Msgn1,
Myf5, Seb4 and Tbx6. Loss of MyoD has no effect on Xbra
expression, which is included in these analyses as a control. We
conclude that the expression of Esr1, Esr2, Msgn1, Tbx6, FoxC1,
Seb4 and Myf5 requires MyoD during gastrula stages. To assess
whether MyoD is sufﬁcient to activate these genes in a naı¨ve
tissue, mRNA coding for XtMyoD was injected into the animal
hemisphere of a Xenopus embryo at the 2-cell stage. Animal cap
explants were taken at blastula stages, cultured until mid-
gastrula stage 11.5 and cDNA was prepared for analysis by qPCR.
The graph in Supplementary Fig. S1B shows that the expression of
some genes (Esr1, FoxC1, Msgn, Tbx6 and Seb4) is dramatically up-
regulated by MyoD in animal caps, while the expression of others
is not affected. As previously demonstrated, MyoD is not sufﬁ-
cient to activate the expression of Myf5 in animal caps (Fisher
et al., 2003; Hopwood et al., 1991). The expression of Xbra is
included as a control and its expression is not affected by the
over-expression or knock-down of MyoD.
Temporal and spatial expression consistent with a role in myogenic
determination
To determine whether these putative early targets of MyoD are
expressed in cells in the myogenic lineage in vivo, we analysed
their expression by whole mount in situ hybridisation. Fig. 3
shows the expression of Esr1, Esr2, FoxC1, Msgn1, Seb4, Tbx6, Myf5
and MyoD at gastrula (NF St11), neurula (NF St18) and tailbud
(NF St28) stages. The last column is a graph depicting the relative
temporal expression of each gene; each of these target genes
(green line) are activated prior to a-cardiac actin (red line) and
after or concurrently with MyoD (blue line). The expression of
these genes is consistent with being early transcriptional targets
of MyoD; at gastrula stages they are expressed in the mesoderm
around the blastopore and at neurula stages in the posterior
mesoderm. In addition to Esr1 expression in the early mesoderm
(arrowheads), Esr1 also has distinct expression in the presumptive
Table 1
Fold change in gene expression in MyoD knock-down relative to control embryos as assayed by microarray. Fold change in gene expression in MyoD AMO injected
embryos relative to control at gastrula stage is shown in the fourth column. The results from over-expressing MyoD in animal caps are shown in the ﬁfth column.
The targets selected for further analysis in this paper are highlighted in blue.
Name GenBank Unigene MyoD knock-down
(fold change)
P-value MyoD overexpression
in animal caps (fold change)
Zinc ﬁnger protein BP712401 Xl.4577 0.19 0.0163972 NA
ESR-2 BC081216 Xl.22609 0.24 0.0018368 7.74
ESR-1 BC043639 Xl.8440 0.26 0.0099701 5.42
MSGN1 BJ034278 Xl.483 0.26 0.0181057 NA
FGFr2 BJ061488 Xl.13358 0.28 0.033043 3.47
Xmyf-5 X56738 Xl.146 0.29 0.0004547 NA
Brachyury-like T-box transcription factor DC119711 Xl.933 0.3 0.043709 0.66
Cyclin D1 X89475 Xl.2595 0.31 0.0400338 0.46
Tbx6 BJ056948 Xl.7697 0.34 0.0353905 1.3
MGC82719 BC073507 Xl.20056 0.44 NS 4.84
Epid21 BC099045 Xl.7213 0.45 0.0289373 4.76
FoxC1 BJ077992 Xl.180 0.46 0.0064953 3.99
Transcription initiation factor IIA (TFIIa) BJ644425 Xl.14633 0.51 0.0222146 3.17
Proto-oncogene c-myc II BJ057211 Xl.1155 0.52 0.0356929 NA
Cleavage stimulation factor 3 (cfst3) BC077522 Xl.24776 0.53 NS 3.6
SEB4 AF223427 Xl.12316 0.56 0.0053694 8.2
Similar to PACT DC097832 Xl.25792 0.56 0.0418064 0.52
Sulfotransferase, cytosolic, 1A BJ087267 Xl.7307 0.56 0.012062 NA
Transcribed locus AW460550 Xl.11594 0.56 0.0029617 3.63
TOB1 (MGC68457) BC060329 Xl.6421 0.62 NS 3.27
Ribosomal protein like BG038869 Xl.13725 0.69 0.0418064 2.2
NF-E2 (hypothetical LOC495834) BC086473 Xl.23579 0.79 0.0103179 3.43
Transcribed locus BG893004 Xl.18867 0.79 0.0301536 3.76
Pinhead BG551973 Xl.23480 0.8 0.0225922 3.78
Similar to roundabout homolog 3 (ROBO3) BP702332 Xl.24897 0.82 NS 11.12
WD40 domain containing similar to WDRPUH BJ088741 Xl.9077 0.83 0.0036343 2.31
Angiotensin receptor like 1b BC046659 Xl.34 0.93 0.0497839 2.93
Hypothetical protein MGC115516 BC097804 Xl.25478 0.93 0.0301295 3.81
Matrix metalloproteinase 13 (collagenase 3) BJ043647 Xl.9058 0.93 NS 4.89
MAP1 light chain 3-like BC056047 XL.14237 0.94 NS 3.38
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columns at neurula stages, and in large parts of the CNS at tailbud
stages. Esr2 shows stronger expression in the mesoderm during
gastrula and neurula stages than Esr1 and is also expressed in the
CNS at tailbud stages. At later stages, some level of expression for
each of these genes is found in the tailbud mesoderm that will
generate the somites of the extending tail and give rise to skeletal
muscle (Davis and Kirschner, 2000; Tucker and Slack, 1995). The
expression of Tbx6, Myf5 and Seb4 is also found in the somites
during tailbud stages; Seb4 is also expressed in the heart at later
stages (Fetka et al., 2000).
Target validation
In order to validate these putative transcriptional targets of
MyoD identiﬁed in our microarray screen, the effective morpho-
lino combination was injected unilaterally into one blastomere at
the 2-cell stage and the embryos were allowed to develop to NF
stage 11.5 when they were ﬁxed and assayed by ISH for the
expression of the selected target genes (Fig. 4, second column).
For all target genes analysed, between 67 and 76% of the embryos
analysed showed reduced expression on the antisense morpho-
lino injected side. The number of embryos analysed in these
experiments is shown in the Supplementary data (Supplementary
Table S1) and the results are shown to be statistically signiﬁcant
(Supplementary Table S2).
To assess the ability of MyoD over-expression to up-regulate
the expression of the putative target genes in developing
embryos, mRNA coding for MyoD was injected into one cell at
the 2-cell stage and the resulting embryos were analysed at NF
stage 11.5 (Fig. 4, third column). MyoD overexpression has noeffects on the expression of Myf5, while the expression of all the
other targets is increased in the mesoderm in at least 83% of the
embryos analysed. It is interesting that distinct target genes
respond differently to MyoD overexpression; the expression of
Seb4 is dramatically up-regulated throughout the injected side,
while other targets including Esr1, Esr2, FoxC1, mesogenin and
Tbx6 are up-regulated by MyoD but their expression is restricted
to the mesodermal ring around the blastopore, suggesting that
important co-factors are only present in the mesoderm or that
powerful repressors are present outside this region. Xenopus Seb4
has previously been shown to be regulated by MyoD in a study
using the overexpression of MyoD-GR and MyoD-EnR (Li et al.,
2010). Myf5 is not up-regulated by MyoD overexpression, con-
sistent with previous reports (Fisher et al., 2003; Hopwood et al.,
1991) suggesting that Myf5 expression requires additional reg-
ulators that are limited and tissue speciﬁc. The ability of MyoD to
activate the expression of these targets in naı¨ve animal cap
explants was also tested (Supplementary data Fig. S1B) and
largely consistent with these ﬁndings.
To conﬁrm that the reduced expression seen in the knock-
down embryos is speciﬁcally due to the lack of MyoD, mRNA
coding for MyoD was co-injected with the morpholino to assess
its ability to rescue gene expression (Fig. 4, fourth column). In at
least 71% of the embryos analysed, gene expression was rescued
by co-injecting the AMOs with mRNA coding for XtMyoD, a
transcript that lacks the morpholino target sequences. Xenopus
brachyury (Xbra) is expressed throughout the early mesoderm
(Smith et al., 1991) and its expression was analysed as a control
(Fig. 4H). The ﬁnding that Xbra expression is not effected by over-
expression or knock-down of MyoD shows that the mesoderm in
general is not being disrupted and supports the argument that
Fig. 3. Expression patterns of shortlisted targets. In situ hybridisation analysis of Esr1, Esr2, FoxC1, mesogenin (MSGN1), Myf5, SEB4 and Tbx6 expression patterns at gastrula,
neurula and tailbud stages. All the putative target genes are expressed circumblastoporally at gastrula stages. After gastrula stages, many of the targets are still expressed
in the posterior mesoderm in the tailbud region of the embryo, which is the source of myogenic progenitors at this stage. On the right, a temporal expression proﬁle, based
on microarray data, is shown for each putative target genes depicting relative expression levels from NF stage 8 to stage 15. The expression of MyoD is shown in the three
bottom panels for comparison.
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transcriptionally regulated by MyoD.
MyoD interacts directly with regulatory regions in the Esr1, Esr2,
Seb4, FoxC1, and Myf5 genes
In order to activate transcription, MyoD forms heterodimers
with E-proteins and binds a consensus sequence (CANNTG) called
an E-box (Blackwell and Weintraub, 1990). E-boxes have been
identiﬁed in the regulatory regions of many muscle-speciﬁc genes
(Weintraub et al., 1991). We used multiple genome alignments to
identify conserved sequences around the putative target genes,
outside of coding regions, as the presence of conserved sequences
would indicate that the region is under selection pressure and
could be involved in the regulation of gene expression. Human,
chicken, zebraﬁsh and mouse genomes were compared to X.
tropicalis genomic sequences in order to provide a good coverage
of evolutionary distance (alignments shown in Supplementary data).E-boxes were found in regions around Esr1, Esr2, FoxC1, Myf5 and
SEB4, including two in the 3’ UTR of SEB4 and one in the coding
region of FoxC1 (Fig. 5 and Supplementary data). No conserved
E-boxes were found in the proximal promoters ofmesogenin or Tbx6.
Furthermore, because of their position at the end of the X. tropicalis
genome scaffolds and a relatively poor degree of synteny it was not
possible to perform a longer range analysis than this. In a recent
study by Li et al. (2010) ﬁve E-boxes were found within 650 bp of
the transcriptional start site of X. tropicalis SEB4 and found to be
responsive to MyoD. However, these sequences are not conserved in
other vertebrates and as such were not included in our study.
It has recently been shown that MyoD binds to many promoters
and modiﬁes chromatin throughout the genome in mice (Cao et al.,
2010) and invertebrates (Lei et al., 2010). We have investigated the
chromatin conformation ﬂanking our putative MyoD targets using
data available through www.xenbase.org. Work from Gert Veenstra’s
lab using ChIP-seq identiﬁes regions of the X. tropicalis genome
that feature Histone 3 Lysine 4 and Lysine 27 tri-methylation
Fig. 4. Validation of the effect knocking down MyoD on shortlisted targets. Embryos were injected unilaterally with 10 ng of Morpholino A and 30 ng of Morpholino B
(knock-down), 2.5 ng XtMyoD mRNA (overexpression) or both (rescue). Control embryos were injected with the equivalent amount of control MO. The injected side is
shown by an asterisk. Numbers and percentages indicate the number of embryos with the phenotype shown. Numbers are from several experiments. The knock-down of
MyoD protein causes the loss of expression of all shortlisted targets. Overexpression of MyoD up-regulates the expression of most targets, with the exception of Myf5.
Target expression is rescued effectively for all targets when XtMyoD mRNA is coinjected with morpholino. Xbra is expressed in all mesoderm and is included as a control.
Embryos have been analysed at mid-gastrula NF stage 11.5 and are viewed vegetally. For numbers and statistical analysis see Supplementary data Table S1.
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Fig. 5. MyoD binds directly to genomic sequences of target genes. Chromatin immunoprecipitation (ChIP) analysis of conserved E-boxes in target genes. Alignments of
several vertebrate genomes were used to identify conserved E-boxes proximal to the putative target genes (see Supplementary data) and primers were designed to amplify
these regions of genomic DNA. Embryos were analysed at NF stage 11.5 by ChIP using the MyoD antibody D7F2. Above shows that MyoD is capable of binding to conserved
E-boxes found in the genome near Myf5 (Myf5.b, 1.2 Kb), ESR1 (ESR1.b, 212 bp), ESR2 (ESR2.a, 6.3 Kb), FoxC1 (FoxC1.a, þ1.3 Kb), and SEB4 (SEB4.a þ8746, SEB4.b
þ9411). MyoD does not bind to distant E-boxes found in the 5’genome upstream of SEB4 and Myf5 (SEB4.d, SEB4.e, Myf5.c), or the 5’upstream region of ESR1 (ESR1.a).
PCR products present in the ChIP lane that are indistinguishable from the negative control lane are considered a negative result (SEB4.b). All diagrams are to scale (note the
doubled scale for the SEB4 outline). Distances given are from transcriptional start sites. Red triangles represent E-boxes bound by MyoD, black triangles E-boxes found not
to be bound by MyoD.
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These modiﬁcations indicate transcriptionally active regions of
DNA, or regions of potentially localised gene expression (Akkers
et al., 2009). The H3K4me3 is associated with active promoters
and enhancers (Santos-Rosa et al., 2002) and we have found that
this mark is present in regions overlapping or close to the E-boxes
identiﬁed in our analyses of the putative gene targets regulated
by MyoD (see Supplementary Fig. S3).
In order to determine whether MyoD directly interacts with
the identiﬁed E-boxes Chromatin immunoprecipitation (ChIP)
was carried out using XtMyoD injected X. tropicalis embryos and
the D7F2 Xenopus MyoD antibody. Primers were designed to the
relevant X. tropicalis genome sequence and ChIP was carried as in
Blythe et al. (2009). An unconjugated mouse IgG was used as a
negative control for immunprecipitation. We found that each of
the putative target genes analysed had at least one E-box that
interacted with MyoD protein (Fig. 5). The E-box pair in Myf5.b
was the only region identiﬁed in our Myf5 alignment to be pulled
down with MyoD. This region is located within a 785 bp fragment
known as the MRR that was previously shown to contain
elements required for the normal regulation of Myf5 expression
in embryos (Polli and Amaya, 2002).
Somite morphology is disrupted in Xenopus embryos lacking MyoD
As several of the early transcriptional targets of MyoD identiﬁed
are known to be important for somitogenesis (Cha et al., 2007;
Kume et al., 2001; Oginuma et al., 2008; Tazumi et al., 2008;Topczewska et al., 2001; Wang et al., 2007; White et al., 2003;
Yoon and Wold, 2000), we directly assessed the morphology of
somites in MyoD knock-down embryos. We used immunohisto-
chemistry and histology to examine somite structure at swimming
tadpole stages (NF stage 40). We used the antibody 12–101 to detect
skeletal muscle and anti-laminin to detect somite boundaries. We
have also used DAPI staining to mark the nuclei which are known to
align neatly down the middle of the mononucleated myoﬁbres that
span the length of a somite in Xenopus embryos.
Unsurprisingly, 12/101 staining shows that differentiated
skeletal muscle is present in embryos lacking MyoD, consistent
with ﬁndings in mice (Kassar-Duchossoy et al., 2004; Rudnicki
et al., 1993). Anti-laminin staining shows that somite boundaries
form (Fig. 6A and B), but can be irregular and reveal that the
overall shape of some somites is more rounded (Fig. 6B) and
unlike the sharp chevron shape typical of somites (Fig. 6A). By
analysing both 12–101 to show the muscle ﬁbres and laminin to
show the somite boundaries (arrowheads), we have found that at
anterior positions, some muscle ﬁbres cross the somite bound-
aries (Fig. 6C and C’). This is also seen using 12–101/DAB staining
(Fig. 6D and D’) where the morpholino injected side has blue
nuclei due to the lineage marker (indicated by asterix). In some
regions, the muscle ﬁbres have not aligned correctly and some
ﬁbres cross somite boundaries. Studies in zebraﬁsh have shown
that when somite boundaries do not form properly, morphogen-
esis of muscle cells can be disrupted (Henry et al., 2005). Our
results from histological analysis also show this disruption: some
muscle ﬁbres cross the somite boundaries on the side of the
Fig. 6. MyoD is required for somite morphogenesis. (A) and (B) each depict a plane of focus from a Z-stacked confocal image of an embryos in which MyoD has been
knocked down unilaterally and immunostained with anti-laminin. (A) is the control side of the embryo and (B) is the morpholino injected side. (C and C’) show a
cryosection of an embryo unilaterally injected with MyoD AMO and immunostained with 12/101 and anti-laminin; the nuclei have been labeled with DAPI. The top is the
control side and the arrow heads mark out normal tight somite boundaries. (C’) shows a magniﬁcation of the disrupted somite boundary on the myoD knock-down side.
(D and D’) show a vibratome section of an embryo unilaterally injected with MyoD AMO and mRNA coding for NLS-beta-galactosidase immunostained with 12/101. The
top side is the control side and the arrow heads mark out the normal somite boundaries. The MyoD knock-down side is at the bottom of the panel and the blue nuclei
indicate it is the injected side. (D’) shows a magniﬁcation of the disrupted somite boundary on the myoD knock-down side. (E and E’) show a parafﬁn wax section of an
embryo unilaterally injected with MyoD AMO (bottom side) and stained with borax carmine and picro-blue-black. The normal somite boundaries are indicated by arrow
heads on the control side. All specimens are at NF stage 35 and the somites shown are anterior to mid-way along the axis. The confocal images in (A and B) were taken
sagitally through the embryo. The sections shown in (C–E) are frontal sections. (C’), (D’), and (E’) are each a magniﬁed ﬁeld of the panel to its right showing the myoﬁbres
crossing the weak somite boundaries. Scale bars are 500 mm. Scale bar in (A) is for (A and B); scale bar in (C) is for (C, D and E); scale bar in (C’) is for (C’, D’, E’).
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not occur all along the axis, but only in a few anterior somites. It
has previously been shown that overexpressing a dominant
negative form of Delta2 can cause a similar, but more widespread
disruption of somites (Jen et al., 1997); the effects caused by
knocking-down MyoD are milder and localised to only a few early
forming somites.
Hatching is delayed in Xenopus embryos lacking MyoD
Functional analyses of the myogenic regulatory genes in mice
have established redundant roles for MyoD and Myf5 in the
determination of myogenic cell lineage, where the presence ofone or two alleles of either regulator can support myogenesis
(Rudnicki et al., 1993). It is not surprising that when MyoD is
knocked-down in Xenopus, skeletal muscle develops and by NF
stage 40 tadpoles swim normally. Xenopus embryos hatch from the
vitelline membrane at about NF stage 28 using strong coordinated
twitching movements. We found that embryos in which MyoD is
knocked-down (n¼34) the average hatching time was delayed by a
period of approximately 12 h at 23 1C when compared to embryos
injected with control morpholino (n¼28). A Wilcox rank sum test
on this data shows that this result was statistically signiﬁcant
(P¼0.05). From these observations we conclude that although
skeletal muscle differentiates in these embryos, there is a signiﬁ-
cant delay before it becomes fully functional.
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To determine when MyoD is required for the expression of
these genes during early development, we have analysed gene
expression in sibling embryos at NF stage 11 (gastrula) and NF
stage 14 (neurula) when MyoD is knocked-down as compared to
embryos injected with control morpholino oligo. Mesogenin and
Tbx6 are expressed in the presegmental mesoderm (PSM) during
neurula stages when somites begin to segment from the posterior
mesoderm and we have analysed the effects of MyoD knock-
down on the expression of these genes at this stage. Fig. 7(A–F)
shows embryos unilaterally co-injected with mRNA coding for
beta-galactosidase together with morpholino oligos, such that the
injected side in each panel is apparent by the presence of pale
blue nuclei and is labelled with an asterix. In contrast to the
dramatic down regulation of Mesogenin and Tbx6 expression on
the MyoD knock-down side at gastrula stages (Fig. 7A and D; also
see Fig. 4), at neurula stages the expression of these genes in the
posterior mesoderm has largely recovered (Fig. 7C and F). qPCR
data also indicate that this set of genes require MyoD for the
activation of expression in the mesoderm during gastrula stages
(stage 11), but at later stages (stage 14) the expression of these
genes is independent of MyoD (Fig. 7G).
To assess the earliest formation of somites we used Delta2
expression as a marker (Fig. 7H–O). At open neural plate stages,
Delta2 is expressed during the earliest segmentation of the paraxial
mesoderm (arrows Fig. 7H). When MyoD is knocked-down unilat-
erally (Fig. 7I and J; knock-down side marked with an asterix), thisFig. 7. A transient requirement for MyoD. (A–F) Embryos were unilaterally co-injected
amount of control MO. The injected side is marked with an asterix. (B and E) are i
hybridisation shows Tbx6 (A–C) andmesogenin (D–F) expression. (A and D) are gastrula s
(G) qPCR shows levels of target gene expression in sibling embryos at gastrula stage 11
and the Ct values from three technical replicates and primer efﬁciency were then expor
conﬁdence interval of the mean fold change. (H–O) In situ hybridisation shows Delta2
either MyoD AMO or control MO. (H, K, and N) are control MO injected, while (I, J, L, M,
dorsally, and Delta expression shows the ﬁrst segmentation of somites. (K–M) are stag
shown. Arrows indicate forming somites. (P) A frontal section through a Stage 21 (7–8
MyoD AMOs (asterix). The structure of the somite cells is revealed by staining with anti
are numbered on the control side for reference. On the control side, we have highlighted
that occurs. On the MyoD knock down side we also highlight cells at progressive point
disorganized (arrow heads).early expression of Delta2 is lost. In contrast, at later neurula stages,
Delta2 continues to be expressed on the side of the embryo lack-
ing MyoD (asterix side Fig. 7L and M) but its expression indicates
that segmentation is shifted slightly to the anterior (note the
position of the arrows). By tailbud stages (Fig. 7N and O), Delta2 is
expressed in two stripes (see arrows) in the posterior paraxial
mesoderm in embryos injected with control morpholino (Fig. 7N)
as well as embryos injected with morpholinos targeted against
MyoD (Fig. 7O). This suggests that the effects of MyoD on somito-
genesis are transient, as the expression of Delta2, and the other genes
analysed are sensitive to the loss of MyoD at early stages but not
later. This transient effect is also apparent from the somite pheno-
type that is restricted to anterior region of the trunk. In Fig. 7O some
disruption of somite structure can be seen by the failure of the blue
nuclei to align in anterior somites (see also Supplementary Fig. S5).
We also looked directly at the formation of somites from the
paraxial mesoderm of late neurula/early tailbud (NF stage 21) using
immunohistochemistry (Fig. 7P). The MyoD knock-down side
(asterix) is labelled with RFP (red), and the cell morphology is
revealed by staining with anti-beta catenin (green) which labels cell
membranes and DAPI (blue) which labels nuclei. On the right
(control) side, we have used an imaging tool to label a single cell in
the pre-segmental mesoderm (PSM) which shows a typically elon-
gated cell oriented perpendicular to the notochord. As somites form,
the cells rotate to a position parallel to the axial structures (note the
highlighted cells in S0, SI, and SII on the control side of Fig. 7P).
In the absence of MyoD (side labelled with an asterix), we were
unable to ﬁnd any elongated cells to highlight in the PSM. In morewith mRNA coding for nucLacZ together with either MyoD AMO or the equivalent
njected with control MO, (A, C, D, and F) are injected with MyoD AMO. In situ
tage 11, viewed vegetally. (B, C, E, and F) are neurula stage 19 and viewed dorsally.
(blue bars) and neurula stage 14 (red bars). All qPCR data were normalized to ODC
ted into REST
TM
2008 software for statistical analysis. Error bars represent the 95%
expression in embryos co-injected with mRNA coding for nucLacZ together with
and O) are injected with MyoD AMO. (H–J) are open neural plate stage 13, viewed
e 19, viewed dorsally. (N and O) are stage 30 viewed laterally and injected side is
somites) embryo that has been unilaterally co-injected with membrane-RFP and
-beta-catenin (green) and nuclei are marked with DAPI (blue). The forming somites
a single cell in the PSM/somitomere, S0, SI and SII to draw attention to the rotation
s in their rotation; we were unable to highlight a cell in the PSM as the cells were
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some elongated cells in the process of rotating; these cells tend to
be thinner and restricted to medial positions. In addition the nuclei
are delayed in aligning on the MyoD knock-down side (arrows)
while the contralateral somitic nuclei are aligned by SIII. This
analysis suggests that in the early tailbud (stage 21) the mechanism
of somitogenesis is disturbed in the absence of MyoD, and the
effects of this are apparent later as malformed anterior somites.Discussion
A set of genes transcriptionally activated by MyoD in the early
mesoderm
One interesting ﬁnding from our analysis is that Myf5 requires
MyoD for its early expression in the gastrula stage Xenopus embryo.
This is in contrast to the relationship of these genes in the mouse,
wheremyf5 is the ﬁrst MRF gene expressed in the epaxial part of the
somite as a response to Shh signalling (Borycki et al., 1999; Ott et al.,
1991) and Myf5 is required to activate the expression of myoD
(Tajbakhsh et al., 1997). It is implicit that additional Myf5-
independent mechanisms exist to activate myoD, as the expression
ofmyoD is only delayed and not absent inmyf5mutant mice. In light
of our results it is interesting to note that the formation of the
myotome is delayed inmyf5 null mice (Kaul et al., 2000). In zebraﬁsh,
myoD and myf5 are essential, but redundant, for the earliest, medial
myogenesis (Hinits et al., 2009). However, in contrast to our ﬁndings,
myf5 is expressed normally in ﬁsh myoD morphants (Hinits et al.,
2009). The timing of the analysis in the zebraﬁsh study was at somite
stages, while our work analysed gene expression at gastrula stages
and it is possible that the regulatory relationships among the MRFs
are different at earlier stages. A single element upstream of Xmyf5,
containing the E-box identiﬁed in Fig. 5, has been shown to be
necessary and sufﬁcient for correct Xmyf5 expression during gastrula
stages in Xenopus (Polli and Amaya, 2002), while in mouse there are
multiple interdigitated control sequences required for myf5 expres-
sion during somite stages (Summerbell and Rigby, 2000).
Another gene we found to require MyoD for its expression is Seb4,
which has previously been recognised as having a role in myogenesis
(Li et al., 2010). Seb4 codes for an RNA binding protein and its
Caenorhabditis elegans orthologue, Sup-12, was shown to be a muscle
speciﬁc splicing factor (Kuroyanagi et al., 2007). The expression of
Seb4 in frogs is remarkably similar to that of MyoD, with additional
domains of expression in the heart and retina (Fetka et al., 2000).
Tbx6 is also known to be important for skeletal muscle develop-
ment (Chapman et al., 2003; Mitani et al., 1999; White et al., 2003).
Injection of mRNA coding for Xenopus Tbx6 induces the expression of
a-cardiac actin in animal cap explants (Uchiyama et al., 2001). When
Tbx6 is knocked down in frogs, the expression of both XWnt8 and
FGF8 are markedly reduced and when Tbx6 is injected into animal
caps, both are up-regulated (Li et al., 2006; Lou et al., 2006). Since
both Wnt8 and FGF8 are known to activate MyoD expression
(Fletcher and Harland, 2008; Hoppler et al., 1996), and we have
shown that MyoD regulates Tbx6 expression, these data point to a
model where MyoD acts in a feed-forward circuit, in addition to auto-
regulating its own expression (Cao et al., 2010; Thayer et al., 1989).
Effectors of notch signalling are transcriptional targets of MyoD
Esr1 and Esr2 code for effectors of the Notch signalling path-
way and we have shown here that these genes require MyoD for
their expression during gastrula stages. In addition, there is a
weight of evidence that Tbx6, mesogenin and FoxC1 act genetically
upstream of Notch signalling during somitogenesis. In mouse, a
hypomorphic Tbx6 mutant expresses signiﬁcantly lower levels ofthe Notch target gene and ligand, Delta1 (Beckers et al., 2000).
Furthermore, Tbx6 binding sites upstream of Delta1 are required
for its normal expression (White and Chapman, 2005). Previous
experiments in Xenopus found that MyoD transcriptionally acti-
vates the expression of the Notch ligand Delta1 (Wittenberger
et al., 1999) at the same early time point analysed in our study.
Delta1was not identiﬁed in our analyses as it is not present on the
Affymetrix GeneChip Xenopus leavis 1.0 array.
Notch signalling is important for maintaining a population of
myogenic precursors, and MyoD may be involved in this process by
regulating Esr1 and Esr2, as well as Delta1 (Wittenberger et al.,
1999) in early determined myoblasts. Notch signalling has been
shown to be important in regulating the choice between differ-
entiation and self-renewal in myogenic progenitors; a mouse with a
hypomorphic Delta allele shows reduced amounts of skeletal
muscle due to the premature differentiation of progenitor cells
(Schuster-Gossler et al., 2007). Similar effects are seen in mice
where the effector of Notch signalling, RBP-J, has been knocked-out
speciﬁcally in muscle cells (Vasyutina et al., 2007). Together, these
data suggest that Notch plays a role in myogenesis analogous to its
well established role in neurogenesis, where activation of the Notch
signalling pathway prevents differentiation and maintains popula-
tions of precursor cells. Given the targets identiﬁed in this paper, it
is appears that MyoD plays a role in the transcriptional network
regulating the expression of some genes important for Notch
signalling in the skeletal muscle cell lineage.
The Notch signalling pathway is also a key regulator of
somitogenesis (Dequeant et al., 2006). Cyclic expression of HES
genes in the anterior PSM is a key feature of the somitic clock, and
cHairy1 was ﬁrst of these genes found to cycle during chick
somitogenesis (Palmeirim et al., 1997). It is now known that the
speciﬁc HES genes that show cyclic expression vary among
vertebrates (Krol et al., 2011). In Xenopus, only the expression of
Esr9 (Li et al., 2003) and Esr2 (Blewitt, 2009) has been shown to
cycle in the posterior mesoderm at neurula stages. In a recent
transcriptomic analysis Hes5 and Hes1 orthologues were found to
be uniquely conserved as cycling genes in chick, mouse and
zebraﬁsh (Krol et al., 2011) The X. tropicalis orthologues of X.
laevis Esr1 and Esr2 are annotated as Hes 5.1 and Hes 3.3,
respectively. Our in silico analyses suggest Esr2 (Hes3.3) is closely
related to Esr1 (Hes5.1) and these genes group together with Esr9
and with human Hes5 on the same branch of an unrooted
phylogenetic tree of Hes genes (Supplementary Fig. S4). This
suggests that consistent with what has been described for chick,
mouse and zebraﬁsh, the cycling genes in frogs are Hes5 related.
Hes6 has been found to inhibit cell cycle withdrawal and
skeletal muscle differentiation in both Xenopus and C2C12 cells
(Cossins et al., 2002). These activities of Hes6 were found to be
independent of its ability to bind DNA, but require the WRPW
domain, suggesting an important role for protein–protein inter-
action. Hes6 is known to interact with other transcriptional
regulators via this domain, in particular Groucho/TLE4 (Murai
et al., 2007) which has been shown to inhibit MyoD expression in
gastrula stage Xenopus embryos (Burks et al., 2009). MyoD is
activated in the Xenopus mesoderm by FGF signalling (Fletcher
and Harland, 2008; Fisher et al., 2002), which can inhibit the
repressive activity of Groucho and Hes6 (Murai et al., 2007; Burks
et al., 2009). Together these studies put Hes6 regulation of
myogenesis upstream of MyoD; interestingly, overexpression of
Hes6 leads to disrupted somite formation similar to those
described in our study (Cossins et al., 2002).
Notch maintains progenitor populations in many cell lineages,
including skeletal muscle (Brack et al., 2008) and MyoD is essential
for the establishment of myogenic progenitors (Rudnicki et al.,
1993). Our ﬁnding that MyoD regulates components of the Notch
pathway, Esr1 and Esr2, establishes a previously unsuspected link
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speciﬁcation. It is interesting that several MyoD targets, in addition
to Esr2, are known to be important for the segmentation of somites.
The mouse knockout of Msgn1 exhibits a complete failure of
somitogenesis (Yoon and Wold, 2000). FoxC1 is essential for
somitogenesis in zebraﬁsh (Topczewska et al., 2001), while
Msgn1and Tbx6 have been found to interact during somite devel-
opment in Xenopus (Oginuma et al., 2008; Tazumi et al., 2008). It is
worthwhile noting that other studies have used large-scale gene
analyses to investigate targets of MyoD in cultured muscle cells using
forced expression of MyoD (Bergstrom et al., 2002; Wyzykowski
et al., 2002), and analysing primary myoblasts fromMyoD knock-out
mice (Ishibashi et al., 2005). None of the genes we describe here
were identiﬁed in these studies using cultured cells; it is unlikely
that the set of genes described here could have been identiﬁed using
anything but an in vivo approach.
A MyoD-like transcription factor co-ordinated myogenesis with
somitogenesis?
Somites are transient embryonic structures that are character-
istic of vertebrates. They arise progressively in the posterior of the
embryo from the paraxial mesoderm and ﬁrst appear as blocks of
epithelial cells adjacent to the neural tube and notochord. Signals
from the midline axial tissues are essential for initiating myogen-
esis in the somites (Emerson, 1993). All the skeletal muscles in
the vertebrate body are derived from somites, while other somite
cells give rise to skeletal structures such as the vertebrae and ribs,
and others go on to form the dermis of the skin (Brand-Saberi
et al., 1996; Christ and Ordahl, 1995). In addition, the somites also
provide cues for migrating axons and thereby impart segmental
pattern to the peripheral nervous system (Keynes and Stern,
1984). In this way, the coordinated development of segmented
mesodermal derivatives of the somite promotes the maturation of
an exquisitely patterned musculoskeletal system.
Drosophila, C. elegans and sea urchin each have a single myoD
related gene, while lower chordates have two MRFs: Ciona
intestinalis has one MRF gene coding for two distinct MyoD related
proteins (Meedel et al., 1997) and Branchiostoma ﬂoridae has two
MRF genes (Schubert et al., 2003). There are four MRF genes in most
vertebrate genomes and these genes are redundantly essential for
skeletal muscle development (Kassar-Duchossoy et al., 2004;
Rudnicki et al., 1993). It is possible that during the evolution of
vertebrates, a MyoD-related transcription factor may have provided
a molecular mechanism to link skeletal myogenesis with somito-
genesis by co-regulating the transcription of genes important for
both processes. These processes are now regulated by several bHLH
transcription factors, including those coded for by theMesp and HES
genes (Maroto et al., 2008). Our ﬁndings in Xenopus indicate that
MyoD is transiently essential for the normal activation of transcrip-
tion from a number of segmentation genes during gastrula stages. It
will be interesting to determine whether there is any similar
requirement for MyoD in other vertebrate embryos.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2012.08.027.References
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